Link does not work, but this is MYX’s part: Meanwhile, the Mayne Pharma Group Ltd (ASX: MYX) share price could also lose favour in the coming weeks.The drug supplier is facing persistent and intense pricing pressure from generic medication and demand for its drugs is likely to be soft from the COVID-19 distraction.If there is any delay in the launch of its generic NuvaRing in the current half, brokers may be forced to take an axe to FY21 estimates
Link does not work, but this is MYX’s part: Meanwhile, the Mayne...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M | |||
| Open | High | Low | Value | Volume |
| $5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 810 | $5.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.15 | 2033 | 2 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |